+321 123 4567
info@test.com
My Account
  1. Home
  2. /
  3. Availability
  4. /
  5. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination

Description

We estimated the potential health and economic impact of M72/AS01E and BCG-revaccination in India and investigated the impact of variation in vaccine characteristics and delivery strategies.
WHO goals and milestones
Availability, Economic impact/cost-effectivenss, Epidemiological impact

Project details

Country
India
Timeline
Target group
adolescents, General Adults
Vaccine
BCG revax, M72/AS01e
Type of protection of vaccine
Prevention of disease, Prevention of infection
Type of research
Modelling
Partners involved
BMGF; LSHTM; Harvard University; Boston University; KNCV; Sanofi Pasteur; WHO; MoHFW Govt of India;
Type of project

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?